Your browser doesn't support javascript.
loading
Human Bone Marrow Organoids for Disease Modeling, Discovery, and Validation of Therapeutic Targets in Hematologic Malignancies.
Khan, Abdullah O; Rodriguez-Romera, Antonio; Reyat, Jasmeet S; Olijnik, Aude-Anais; Colombo, Michela; Wang, Guanlin; Wen, Wei Xiong; Sousos, Nikolaos; Murphy, Lauren C; Grygielska, Beata; Perrella, Gina; Mahony, Christopher B; Ling, Rebecca E; Elliott, Natalina E; Karali, Christina Simoglou; Stone, Andrew P; Kemble, Samuel; Cutler, Emily A; Fielding, Adele K; Croft, Adam P; Bassett, David; Poologasundarampillai, Gowsihan; Roy, Anindita; Gooding, Sarah; Rayes, Julie; Machlus, Kellie R; Psaila, Bethan.
Afiliação
  • Khan AO; Institute of Cardiovascular Sciences, College of Medical and Dental Sciences, University of Birmingham, Vincent Drive, Birmingham, United Kingdom.
  • Rodriguez-Romera A; MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine and National Institute of Health Research (NIHR) Oxford Biomedical Research Centre, University of Oxford, Oxford, United Kingdom.
  • Reyat JS; MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine and National Institute of Health Research (NIHR) Oxford Biomedical Research Centre, University of Oxford, Oxford, United Kingdom.
  • Olijnik AA; Institute of Cardiovascular Sciences, College of Medical and Dental Sciences, University of Birmingham, Vincent Drive, Birmingham, United Kingdom.
  • Colombo M; MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine and National Institute of Health Research (NIHR) Oxford Biomedical Research Centre, University of Oxford, Oxford, United Kingdom.
  • Wang G; MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine and National Institute of Health Research (NIHR) Oxford Biomedical Research Centre, University of Oxford, Oxford, United Kingdom.
  • Wen WX; MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine and National Institute of Health Research (NIHR) Oxford Biomedical Research Centre, University of Oxford, Oxford, United Kingdom.
  • Sousos N; Centre for Computational Biology, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, United Kingdom.
  • Murphy LC; MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine and National Institute of Health Research (NIHR) Oxford Biomedical Research Centre, University of Oxford, Oxford, United Kingdom.
  • Grygielska B; Centre for Computational Biology, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, United Kingdom.
  • Perrella G; MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine and National Institute of Health Research (NIHR) Oxford Biomedical Research Centre, University of Oxford, Oxford, United Kingdom.
  • Mahony CB; Cancer and Haematology Centre, Churchill Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom.
  • Ling RE; MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine and National Institute of Health Research (NIHR) Oxford Biomedical Research Centre, University of Oxford, Oxford, United Kingdom.
  • Elliott NE; Institute of Cardiovascular Sciences, College of Medical and Dental Sciences, University of Birmingham, Vincent Drive, Birmingham, United Kingdom.
  • Karali CS; Institute of Cardiovascular Sciences, College of Medical and Dental Sciences, University of Birmingham, Vincent Drive, Birmingham, United Kingdom.
  • Stone AP; Rheumatology Research Group, Institute of Inflammation and Ageing, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom.
  • Kemble S; MRC Weatherall Institute of Molecular Medicine, Department of Paediatrics and National Institute of Health Research (NIHR) Oxford Biomedical Research Centre, University of Oxford, Oxford, United Kingdom.
  • Cutler EA; MRC Weatherall Institute of Molecular Medicine, Department of Paediatrics and National Institute of Health Research (NIHR) Oxford Biomedical Research Centre, University of Oxford, Oxford, United Kingdom.
  • Fielding AK; MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine and National Institute of Health Research (NIHR) Oxford Biomedical Research Centre, University of Oxford, Oxford, United Kingdom.
  • Croft AP; Vascular Biology Program, Boston Children's Hospital, Department of Surgery, Harvard Medical School, Boston, Massachusetts.
  • Bassett D; Rheumatology Research Group, Institute of Inflammation and Ageing, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom.
  • Poologasundarampillai G; University College London Cancer Institute, London, United Kingdom.
  • Roy A; University College London Cancer Institute, London, United Kingdom.
  • Gooding S; Rheumatology Research Group, Institute of Inflammation and Ageing, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom.
  • Rayes J; Healthcare Technologies Institute, School of Chemical Engineering, University of Birmingham, Birmingham, United Kingdom.
  • Machlus KR; School of Dentistry, Institute of Clinical Sciences, University of Birmingham, Birmingham, United Kingdom.
  • Psaila B; MRC Weatherall Institute of Molecular Medicine, Department of Paediatrics and National Institute of Health Research (NIHR) Oxford Biomedical Research Centre, University of Oxford, Oxford, United Kingdom.
Cancer Discov ; 13(2): 364-385, 2023 02 06.
Article em En | MEDLINE | ID: mdl-36351055
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos / Tratamento / Transplante_de_medula_ossea Base de dados: MEDLINE Assunto principal: Medula Óssea / Neoplasias Hematológicas Tipo de estudo: Guideline Limite: Humans Idioma: En Revista: Cancer Discov Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos / Tratamento / Transplante_de_medula_ossea Base de dados: MEDLINE Assunto principal: Medula Óssea / Neoplasias Hematológicas Tipo de estudo: Guideline Limite: Humans Idioma: En Revista: Cancer Discov Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Reino Unido